Wang X, Zhou Y, Jiang N, Zhou Q, Ma WL. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved.
Int J Infect Dis 2020;
95:433-435. [PMID:
32353545 PMCID:
PMC7184976 DOI:
10.1016/j.ijid.2020.04.063]
[Citation(s) in RCA: 41] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2020] [Revised: 04/22/2020] [Accepted: 04/22/2020] [Indexed: 12/22/2022] Open
Abstract
Intestine SARS-CoV-2 infection affects the disease course of COVID-19.
The digestive system is the main target organ of SARS-CoV-2 in some patients.
Viral excretion of SARS-CoV-2 in feces.
Management of patients with COVID-19 after discharge should include intestine SARS-CoV-2 infection.
The current reports of COVID-19 focus on the respiratory system, however, intestinal infections caused by SARS-CoV-2 are also worthy of attention. This paper reported persistence of intestinal SARS-CoV-2 infection leads to re-admission after pneumonia resolved in three cases with COVID-19.
Collapse